Skip to content
MedsAcross

Medicine

Diltiazem 60 mg tablet

Diltiazem · Oral
Available on requestPrescription onlyUS FDAGeneric name

Diltiazem 60 mg tablet is a generic prescription medicine for oral use, made by 11 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at 20° to 25°C (68° to 77°F).

Key facts

Active ingredient (INN)
Diltiazem
Brand
Sold under the generic name
Strength
60 mg
Dosage form
Tablet
Route
Oral
Packs
100 tablets, 500 tablets, 120 tablets and 22 more
Manufacturers
Alembic PharmaceuticalsIndiaViona PharmaceuticalsIndiaZydus LifesciencesIndiaA-S Medication SolutionsScieGen PharmaceuticalsNorthwind HealthOceanside PharmaceuticalsTeva PharmaceuticalsAmerican Health PackagingChartwell RX
Origin register
US FDA, United States
Storage
Store at 20° to 25°C (68° to 77°F).
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
C05AE03 Diltiazem
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
5 November 1992
Identifiers
RxCUI 831103, 831054, 831102 +1DailyMed set ID f29febd6-5a27-eb83-e053-2a95a90a5b7d, ab38794a-914d-4bcd-9c6d-1578aa10041a, 43cffe12-304a-4e15-9512-94f812188f1a +11NDC 51655-020, 62332-782, 72578-200 +11Application ANDA074185, ANDA217633, ANDA219253 +3

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
100 tablet, film coated in 1 bottle46708-782-31Alembic PharmaceuticalsIndia14 November 2025
500 tablet, film coated in 1 bottle46708-782-71Alembic PharmaceuticalsIndia14 November 2025
100 tablet, film coated in 1 bottle62332-782-31Alembic PharmaceuticalsIndia14 November 2025
500 tablet, film coated in 1 bottle62332-782-71Alembic PharmaceuticalsIndia14 November 2025
100 tablet in 1 bottle72578-200-01Viona PharmaceuticalsIndia25 May 2026
500 tablet in 1 bottle72578-200-05Viona PharmaceuticalsIndia25 May 2026
100 tablet in 1 bottle70771-1930-1Zydus LifesciencesIndia25 May 2026
500 tablet in 1 bottle70771-1930-5Zydus LifesciencesIndia25 May 2026
120 tablet in 1 bottle62135-334-12Chartwell RX17 June 2024
100 tablet in 1 bottle68682-007-10Oceanside Pharmaceuticals25 December 2010
500 tablet in 1 bottle68682-007-50Oceanside Pharmaceuticals25 December 2010
100 tablet in 1 bottle50228-482-01ScieGen Pharmaceuticals26 September 2022
500 tablet in 1 bottle50228-482-05ScieGen Pharmaceuticals26 September 2022
1000 tablet in 1 bottle50228-482-10ScieGen Pharmaceuticals26 September 2022
30 tablet in 1 bottle50228-482-30ScieGen Pharmaceuticals26 September 2022
100 tablet, film coated in 1 bottle0093-0319-01Teva Pharmaceuticals22 December 1995
500 tablet, film coated in 1 bottle0093-0319-05Teva Pharmaceuticals30 December 1995
30 tablet, film coated in 1 bottle50090-0451-2A-S Medication Solutions29 June 2016
90 tablet, film coated in 1 bottle50090-0451-3A-S Medication Solutions16 May 2018
30 tablet in 1 bottle50090-7401-2A-S Medication Solutions24 October 2024
90 tablet in 1 bottle50090-7401-3A-S Medication Solutions24 October 2024
30 tablet, film coated in 1 bottle, plastic51655-020-52Northwind Health11 August 2022
30 tablet in 1 bottle, plastic82868-024-30Northwind Health3 November 2023
100 blister pack in 1 carton / 1 tablet, film coated in 1 blister pack60687-728-01American Health Packaging8 December 2023
30 tablet, film coated in 1 blister pack0615-8033-39Vangard Labs17 May 2016

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 5 November 1982Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Alternatives

Other makers and brands of Diltiazem 60 mg tablet.

Compare 1

Other strengths and forms of Diltiazem

Clinical summary

Diltiazem is a calcium channel blocker indicated for the management of chronic stable angina and angina due to coronary artery spasm. It is available as extended-release capsules, tablets and extended-release tablets for oral and intravenous use. MedsAcross supplies Diltiazem for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Diltiazem

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Diltiazem 60 mg tablet for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.